Bharat Biotech To Intensify Debate on Vaccine Price

Bharat Biotech's pricing announcement of its COVID-19 vaccine named Covaxin may spark the debate on pricing as the critics have slammed the vaccine manufacturers for 'profiteering'.

from Medindia Health News https://ift.tt/3aIavmW